NCT06083883: Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1 |
|
|
| Suspended | 1 | 44 | US | Fludarabine phosphate, Fludarabine, Fludara®, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide, Cytoxan®, Neosar® | M.D. Anderson Cancer Center | Synovial Sarcoma, Myxoid/Round Cell Liposarcoma | 11/26 | 11/28 | | |
